Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Interventional Cardiology
What techniques do you use in the lab to reduce the amount of contrast that needs to be used in patients with CKD?
Answer from: at Academic Institution
Avoid LV angiogram. Use ECHO instead to assess LV function.
Sign in or Register to read more
Answer from: at Academic Institution
Reducing Fr size Limited views Using co-registration tools Occasional addition of an NS mix
Comments
at Cardiology Associates Of Fairfield County
Using IVUS can also be helpful instead of taking m...
at Johns Hopkins University
Here's a summary! assist injection device cons...
12387
12413
Sign in or Register to read more
24167
23057
Related Questions
In patients with post-MI LV thrombus which resolves after 3-6 months of anticoagulation, would you consider surveillance imaging for thrombus recurrence if there is persistent apical akinesis?
Is there any difference between colchicine 0.5mg vs 0.6 mg for high risk coronary artery disease?
What type of DES should you opt for if a patient has or is concerned about possible nickel allergy?
What factors influence your choice between low-dose DOAC therapy and dual antiplatelet therapy for the first 3 months after percutaneous left atrial appendage occlusion?
When do you consider revascularizing Chronic total occlusions after failing medical management?
How have the findings from DanGer Shock RCT changed your perspective on which patients presenting with acute MI complicated by cardiogenic shock would benefit from Impella for additional hemodynamic support?
What has been your approach to percutaneous intervention for calcified nodules and threshold for intervention?
Based on most current research regarding the more widespread use of class IC antiarrhythmic drugs, what are your prescribing practices in patients with coronary artery disease?
How would you manage cardiac sarcoid with intolerance/contraindications to methotrexate, azathioprine, and mycophenolate/mycophenolic acid and that has proven refractory to adalimumab and infliximab as determined by PET?
Do you recommend transitioning from ticagrelor-aspirin DAPT to ticagrelor monotherapy after 1 month in patients with acute coronary syndrome and average bleeding risk post-PCI to reduce the risk of bleeding?